Clayton, Dubilier & Rice Analysis
What is Clayton, Dubilier & Rice?
Investment Focus
Clayton, Dubilier & Rice (CD&R) primarily focuses on investing in established businesses across various sectors, including business services, consumer/retail, healthcare, industrials, and technology. Their investment strategy emphasizes building stronger, more profitable companies through operational improvements and strategic initiatives. CD&R typically targets middle-market companies and seeks to partner with management teams to enhance value creation over the long term.
Assets Under Management
$66.9 billion
Investment Geography
Clayton, Dubilier & Rice primarily invests in North America and Europe, with a particular emphasis on the United States, Canada, the United Kingdom, Germany, and Italy.
Key Portfolio Companies
Clayton, Dubilier & Rice (CD&R) has a diverse portfolio of companies across various sectors. Here are some key portfolio companies along with brief descriptions of each:
1. **agilon health** (2016) - Focused on healthcare in North America. 2. **American Greetings** (2018) - A consumer, retail, and services company in North America. 3. **Artera Services** (2018) - Operates in the industrials and business services sector in North America. 4. **Belron** (2018) - A European company in the industrials and business services sector. 5. **Carestream Dental** (2017) - A healthcare company based in North America. 6. **Cloudera** (2021) - A technology company in North America. 7. **Covetrus** (2015) - Another healthcare company in North America. 8. **Drive DeVilbiss Healthcare** (2017) - Focused on healthcare in North America. 9. **Epicor** (2020) - A technology company in North America. 10. **Focus Financial Partners** (2023) - Operates in the financial services sector in North America. 11. **Mosaic Health** (2024) - A healthcare company in North America. 12. **Motor Fuel Group** (2015) - A consumer, retail, and services company in Europe. 13. **Veritiv** (2023) - An industrials and business services company in North America. 14. **Zephyr AI** (2021) - A technology company in North America.
Notable Exits
- Motor Fuel Group (MFG) - CD&R is exploring a partial exit from MFG, the UK's largest independent forecourt operator, in a deal valued at approximately $8.8 billion.
- Kito Crosby - CD&R took a minority stake in Kito Crosby, which was acquired from KKR in an all-cash transaction valued at $2.7 billion. - Source: [Alternatives Watch](https://www.alternativeswatch.com/2025/02/12/kkr-exits-kito-crosby-cdr-takes-minority-stake/)
- Sirius Computer Solutions - CD&R completed the sale of Sirius, a leading provider of secure, mission-critical technology solutions, in a transaction valued at $2.5 billion. - Source: [CD&R News](https://www.cdr.com/news/cdr-exits-tech-solutions-leader-in-25-billion-transaction)
- Solenis - CD&R exited its investment in Solenis, a water treatment leader, through a sale to Platinum Equity, with the transaction implying an enterprise value of $5.25 billion. - Source: [PR Newswire](https://www.prnewswire.com/news-releases/clayton-dubilier--rice-exits-investment-in-water-treatment-leader-solenis-301325883.html)
- Diversey - CD&R sold cleaning products maker Diversey for $4.3 billion, marking a significant exit for the firm. - Source: [Private Equity International](https://www.privateequityinternational.com/cdr-in-2-7x-exit/)
Recent Fundraising
Management Team
The management team of Clayton, Dubilier & Rice includes the following key members:
- **Nate Sleeper** - Chief Executive Officer
- **David Novak** - Co-President
- **Rick Schnall** - Co-President
- **Donald Gogel** - Chairman
- **Harsh Agarwal** - Partner
- **Michael G. Babiarz** - Partner
- **Orla Beggs** - Partner, Human Capital
- **Andrew Campelli** - Partner
- **Romain Dutartre** - Partner
- **James G. Berges** - Operating Partner
- **Bill Berutti** - Operating Partner
- **Vindi Banga** - Operating Partner
- **Russell P. Fradin** - Operating Partner
- **Tom Deane** - VP, Fund Transactions
- **Shakeel Amir** - VP, Fund Accounting & Reporting
- **Sam Camens** - Managing Director, Portfolio Health and Welfare
